Methods for nucleic acid amplification

• US 7,585,626 B1
• Filed: 08/19/2004
• Issued: 09/08/2009
• Est. Priority Date: 08/19/2004
• Status: Active Grant

• Current Assignee: Quest Diagnostics Investments Incorporated (Quest Diagnostics Incorporated)
• Original Assignee: Quest Diagnostics Investments Incorporated (Quest Diagnostics Incorporated)
• Inventors: Keen-Kim, Jennifer Dianne, Hantash, Feras
• Primary Examiner(s): Horlick; Kenneth R.
• Assistant Examiner(s): Babic; Christopher M.
• Application Number:
  US10/921,482
• Time in Patent Office: 1,846 Days
• Field of Search: None
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 2525/151 repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
• CPC Class Codes: C12Q 2525/155 incorporating/generating a new priming site
• CPC Class Codes: C12Q 2525/204 specific length of the oligonucleotides

Abstract

Disclosed are methods for amplifying and sequencing target segments of nucleotides. In the method, nucleic acids are amplified using at least two oligonucleotide primers, wherein at least one of the primers contains a complimentary region that hybridizes adjacent to the target segment of nucleotides and an extender region that includes a primer hybridization sequence. Also included are methods of amplification with an extender region includes a sequence encoding a promoter for an RNA polymerase and optionally sequences for translation. The latter amplified products may be used for transcription of a RNA including subsequent translation of the RNA to generate a protein product.

Claims

1. A method for sequencing a target segment of nucleotides in a nucleic acid test sample, said method comprising:

(a) amplifying said target segment of nucleotides using at least two oligonucleotide primers that flank the target segment, wherein at least one of the oligonucleotide primers comprise;

i) a complementary region with a sequence of about 15 to about 25 nucleotides that hybridizes adjacent to the target segment of nucleotides; and

ii) an extender region that includes a primer hybridization sequence wherein said extender region does not hybridize to the target segment of nucleotides and said extender region is not fully complementary to the segment of nucleotides adjacent to which the complementary region of the primer hybridizes in the target nucleic acids, with a proviso that the length of the complimentary region and the extender region excluding the primer hybridization sequence portion of the extender region together represents a contiguous segment of at least, or, about 50 nucleotides; and

(b) determining the sequence of the amplified target segment by priming with an oligonucleotide primer that is complementary to said primer hybridization sequence of the extender region.

2. The method according to claim 1, wherein said target segment comprises less than, or, about 150 nucleotides.

3. The method according to claim 1, wherein said target segment comprises less than, or, about 50 nucleotides.

4. The method according to claim 1, wherein said target segment is a complete exon.

5. The method according to claim 1, wherein said target segment comprises exon 3 of the gene encoding the thyroid hormone receptor-β

(THRB).

6. The method according to claim 1, wherein said target segment comprises exon 2 of the gene, SDHB, a member of the succinate dehydrogenase gene family.

7. The method according to claim 1, wherein said target segment of nucleotides is located in the nucleic acid less than 100 nucleotides away from a repetitive element, a loop, a bulge, a stem-loop structure, triplex DNA, tertiary or quaternary nucleic acid structure, an AT-rich region, a GC-rich region or a polymorphic region.

8. The method according to claim 1, wherein said primer hybridization sequence of the extender region is complementary to a primer used for nucleotide sequencing.

9. The method according to claim 1, wherein said primer hybridization sequence is complimentary to one or more primers selected from the group consisting of T7, T7 promoter, T7 terminator, T3, T3 promoter, M13, M13 forward (M13F), M13 reverse (M13R), and SP6.

10. The method according to claim 1, wherein said extender region is not complementary to the segment of nucleotides adjacent to which the complementary region of the primer hybridizes in the target nucleic acids.

11. The method according to claim 1, wherein said extender region does not hybridize under stringent conditions to said target nucleic acids.

12. The method according to claim 1, wherein said extender region is not subjected to cleavage by restriction enzymes.

13. The method according to claim 1, wherein said sequence of said amplified target segment is determined without a subcloning step.

14. The method according to claim 1, wherein said sequence of nucleic acids is determined by dye-termination sequencing methods.

38. The method of claim 1, wherein the length of the complementary region and the extender region excluding the primer hybridization sequence together represents a contiguous segment of at least 50 nucleotides.

43. The method according to claim 1, wherein the contiguous segment is at least, or, about 60 nucleotides.

44. The method according to claim 1, wherein the contiguous segment is at least, or, about 80 nucleotides.

45. The method according to claim 1, wherein the contiguous segment is at least, or, about 100 nucleotides.

15. A method for amplifying a target segment of nucleotides in a nucleic acid sample for nucleic acid sequence determination, said method comprising:

(a) contacting said nucleic acids in a test sample with at least two oligonucleotide primers that flank a target segment of nucleotides, wherein at least one of said oligonucleotide primers comprise;

i) a complementary region with a sequence of about 15 to about 25 nucleotides that hybridizes adjacent to the target segment of nucleotides; and

ii) an extender region that includes a primer hybridization sequence wherein said extender region does not hybridize to the target segment of nucleotides and said extender region is not fully complementary to the segment of nucleotides adjacent to which the complementary region of the primer hybridizes in the target nucleic acids, with a proviso that the length of the complimentary region and the extender region excluding the primer hybridization sequence portion of the extender region together represents a contiguous segment of at least, or, about 50 nucleotides; and

(b) amplifying said target segment of nucleotides by priming with said primers, wherein said target segment of nucleotides comprises up to, or, about 150 nucleotides and said target segment is located in the nucleic acid less than 100 nucleotides from a genomic region selected from the group consisting of a repetitive element, a loop, a bulge, a stem-loop structure, triplex DNA, tertiary or quanternary nucleic acid structure, AT-rich region, GC-rich region and polymorphic region, and wherein said complementary region of the primer hybridizes to the nucleic acid between said target segment and genomic region.

16. The method according to claim 15, wherein said extender region includes a primer hybridization sequence which can be used for sequencing by primer extension.

17. The method according to claim 16, wherein said primer hybridization sequence is complimentary to one or more primers selected from the group consisting of T7, T7 promoter, T7 terminator, T3, T3 promoter, M13, M13 forward (M13F), M13 reverse (M13R), and SP6.

18. The method according to claim 15, wherein said extender region does not hybridize under stringent conditions to said target nucleic acids.

19. The method according to claim 15, wherein said extender region is not complementary to the segment of nucleotides adjacent to which the complementary region of the primer hybridizes in the target nucleic acids.

20. The method according to claim 15, wherein said extender region is not subjected to cleavage by restriction enzymes.

21. The method according to claim 15, wherein said amplified target segment is sequenced.

22. The method according to claim 21, wherein said sequence of said amplified target segment is determined without a subcloning step.

23. The method according to claim 21, wherein said sequence of said amplified target segment is determined by dye-termination sequencing methods.

24. The method according to claim 15 wherein said target segment comprises less than, or, about 50 nucleotides.

25. The method according to claim 15, wherein said target segment is a complete exon.

26. The method according to claim 15, wherein said target segment comprises exon 3 of the gene encoding the thyroid hormone receptor-β

(THRB).

27. The method according to claim 15, wherein said target segment comprises exon 2 of the gene, SDHB, a member of the succinate dehydrogenase gene family.

39. The method of claim 15, wherein the length of the complementary region and the extender region excluding the primer hybridization sequence together represents a contiguous segment of at least 50 nucleotides.

46. The method according to claim 15, wherein the contiguous segment is at least, or, about 60 nucleotides.

47. The method according to claim 15, wherein the contiguous segment is at least, or, about 80 nucleotides.

48. The method according to claim 15, wherein the contiguous segment is at least, or, about 100 nucleotides.

28. A method for amplifying a target segment of nucleotides in a nucleic acid sample for transcription of the amplified target segment, said method comprising:

(a) contacting a nucleic acid sample with at least two oligonucleotide primers that flank a target segment of nucleotides, wherein at least one of said oligonucleotide primers comprise;

i) a complementary region with a sequence of about 15 to about 25 nucleotides that hybridizes adjacent to the target segment of nucleotides; and

ii) an extender region that includes a sequence encoding a promoter for an RNA polymerase wherein said extender region does not hybridize to the target segment of nucleotides and said extender region is not fully complementary to the segment of nucleotides adjacent to which the complementary region of the primer hybridizes in the target nucleic acids, with a proviso that the length of the complimentary region and the extender region excluding the sequence encoding the promoter for an RNA polymerase portion of the extender region together represents a contiguous segment of at least, or, about 50 nucleotides; and

(b) amplifying said target segment of nucleotides by priming with said primers, wherein said target segment of nucleotides comprises up to, or, about 150 nucleotides and said target segment is located in the nucleic acid less than 100 nucleotides from a genomic region selected from the group consisting of a repetitive element, a loop, a bulge, a stem-loop structure, triplex DNA, tertiary or quanternary nucleic acid structure, AT-rich region, GC-rich region and polymorphic region, and wherein said complementary region of the primer hybridizes to the nucleic acid between said target segment and genomic region.

29. The method according to claim 28, wherein said sequence encoding a promoter for an RNA polymerase is selected from the group consisting of SP6, T3 and T7.

30. The method according to claim 28, wherein said target segment comprises less than, or, about 50 nucleotides.

31. The method according to claim 28, wherein said target segment is a complete exon.

32. The method according to claim 28, wherein said target segment is a portion of a complete exon.

33. The method according to claim 28, wherein said target segment comprises exon 3 of the gene encoding the thyroid hormone receptor-β

(THRB).

34. The method according to claim 28, wherein said target segment comprises exon 2 of the gene, SDHB, a member of the succinate dehydrogenase gene family.

35. The method according to claim 28, wherein said amplified target segment of nucleotides is contacted with an RNA polymerase to transcribe RNA.

36. The method according to claim 35, wherein said RNA is translated.

37. The method according to claim 28, wherein said amplified target segment of nucleotides is cloned into a vector for expression of an RNA or protein product encoded by said amplified target segment of nucleotides.

40. The method of claim 28, wherein the length of the complementary region and the extender region excluding the primer hybridization sequence together represents a contiguous segment of at least 50 nucleotides.

41. The method of claim 28, wherein the target segment of nucleotides comprises at least 150 nucleotides.

42. The method of claim 40, wherein the target segment of nucleotides comprises at least 150 nucleotides.

49. The method according to claim 28, wherein the contiguous segment is at least, or, about 60 nucleotides.

50. The method according to claim 28, wherein the contiguous segment is at least, or, about 80 nucleotides.

51. The method according to claim 28, wherein the contiguous segment is at least, or, about 100 nucleotides.